If you're considering PuppeteerSharp for PDF generation, here's the version of the story that doesn't show up in the "getting started" docs.

Roku TV vs Fire Stick Galaxy Buds 3 Pro vs Apple AirPods Pro 3 M5 MacBook Pro vs M4 MacBook Air Linux Mint vs Zorin OS 4 quick steps to make your Android phone run like new again How much RAM does ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

You can now ask the Gemini app to directly generate “downloadable and ready-to-share files.” Google wants you to “quickly move from a brainstorm to a complete ...

Google has updated Gemini to generate and package downloadable files like PDFs, Word, and Excel directly in the chat. This new feature, available globally, aims to eliminate the need for manual ...

An OpenAI key is required for this application (see Create an OpenAI API key). The OpenAI key must be set in the environment variable OPENAI_API_KEY. In this application, a simple chatbot is ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Want to correct errors or update content in a PDF? Whether you prefer a powerful, corporate-friendly solution or a basic app you can use at no cost, we're here to help you find the right PDF software ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...